Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting

* The abstract of BBT-207 pre-clinical studies is now available at the AACR website * Preclinical data suggests that BBT-207 may have the potential to be positioned as a frontline treatment with the anti-tumor effects in EGFR mutant NSCLC SEONGNAM, South Korea, March 9, 2022 /PRNewswire/ -- B...

2022-03-10 07:00 2426

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

MANILA, Philippines, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of thei...

2022-03-10 07:00 2096

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

JAKARTA, Indonesia, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their...

2022-03-10 07:00 2111

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

SINGAPORE, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 1891

Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Malaysia

KUALA LUMPUR, Malaysia, March 10, 2022 /PRNewswire/ -- Baxter Malaysia, a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney health...

2022-03-10 07:00 5919

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

2022-03-10 07:00 1800

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

BANGKOK, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge of their kidney hea...

2022-03-10 07:00 2186

Baxter launches Know your Score campaign, highlighting the importance of early screening to tackle the growing burden of kidney disease in Asia Pacific

HO CHI MINH CITY, Vietnam, March 10, 2022 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched theKnow Your Score campaign across Asia Pacific (APAC) on World Kidney Day. Know Your Score aims to educate the public on their kidney score[1] as a gauge o...

2022-03-10 07:00 2550

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

- Cystinosis is a rare genetic disease affecting 1 in 100,000-200,000 live births and poses a lifelong risk to those affected. Cystinosis slowly destroys the body's organs including the kidneys, eyes, thyroid, muscles, liver, pancreas, gonads, and brain. - There are currently no curative treatme...

2022-03-10 00:57 3253

Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis

Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin

Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri,...

2022-03-09 23:20 2653

Databricks Introduces Lakehouse for the Healthcare and Life Sciences Industries to Drive Transformation Across Healthcare Ecosystem

As the industry begins to embrace the power of AI, the lakehouse brings patient, research, and operational data together at scale to deliver new innovations in research and care SAN FRANCISCO, March 9, 2022 /PRNewswire/ -- Databricks, the Data and AI company and pioneer of the data lakehouse par...

2022-03-09 22:00 2652

SOPHiA GENETICS HRD Solution Adopted in Asia Pacific

BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies inTaiwan aiming to provide genetic testing to clinicians, is the first institution inAsia...

2022-03-09 21:57 3309

NCCN Expands Resources for Treating Rare Cancer Types

The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes for these rare tumor types; also reaches milestone expanding library of NCCN Chemotherapy Order Templat...

2022-03-09 21:56 2252

NCCN Expands Resources for Treating Rare Cancer Types

English Version of Hands-On Medical VR Developed. Exhibiting At SXSW 2022.

TOKYO, March 9, 2022 /PRNewswire/ -- Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji; hereafter "Jolly Good"), known for developing and providing medical VR solutions and digital therapeutics VR programs, has developed an English version of their VR medical hands-on tracking ...

2022-03-09 21:00 2327

English Version of Hands-On Medical VR Developed. Exhibiting At SXSW 2022.

I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that two poster presentations featuring translational r...

2022-03-09 21:00 2360

Kusum Healthcare recognized as one of Best Places to Work in Philippines for 2022

MANILA, Philippines, March 9, 2022 /PRNewswire/ -- Kusum Healthcare, a leading tech-driven pharmaceutical group, has been recently awarded the Best Place to Work certification inPhilippines for 2022. During the company assessment, 97% of employees recommended the organization illustrating the com...

2022-03-09 20:22 2567

Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting

* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...

2022-03-09 20:00 5168

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

The firm once again participates in the fight against the pandemic by donating robots that support contactless delivery and automatic disinfection SHENZHEN, China, March 9, 2022 /PRNewswire/ -- Pudu Robotics , the global leader in commercial service robots, has dona...

2022-03-09 20:00 3560

Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic

Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma

- XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. - XPOVIO®, in combination with dexamethasone (Xd), gives patients with triple class refractory multiple myeloma, a new treatment option. ...

2022-03-09 19:08 4201

Cappfinity and Lexxic partnership helps organisations embrace neurodiversity in the workplace

LONDON, March 9, 2022 /PRNewswire/ -- HR tech firm, Cappfinity, has announced a new partnership with specialist neurodiversity consultancy, Lexxic, to help businesses create a culture that enables neurodivergent talent to flourish. Operating since 2007, Lexxic was founded by Chartered Occupationa...

2022-03-09 16:55 2405

1 ... 585 586 587588589 590 591 ... 643